Antihistamine Drugs Market
Global Antihistamine Drugs Market Size, Share, and Trends Analysis Report, by Drug Type (H-1 Receptor Antagonist and H-2 Receptor Antagonists), by Application (Flu and Cold, Allergy, Dermatitis, Urticaria, and Others), by End-User (Homecare, Hospitals and Clinics, and Others), Forecast Period (2022-2028)
The global antihistamine drugs market is anticipated to grow at a CAGR of 8.7% during the forecast period. The rising prevalence of allergies across the globe is a major factor driving the growth of the antihistamine drug market. The rising healthcare expenditure due to increasing disposable income levels and initiatives by public and private organizations towards spreading awareness related to the treatment of various allergic reactions will further expand the antihistamine drugs market during the forecast period. Antihistamines drugs work well to relieve symptoms of different types of allergies, including seasonal (hay fever), perennial allergic rhinitis, and indoor and food allergies. The drug is also found its effective applications in the treatment of a variety of other conditions such as stomach problems, colds, anxiety, and more.
The antihistamine drugs market growth is also backed by the increased approvals of the antihistamine drugs developed by the major pharma companies operating in the market. For instance, in January 2021, JB Chemicals and Pharmaceuticals Ltd., announced that the US FDA had approved an abbreviated new drug application (ANDA) for Loratadine tablets USP 10 mg. The medication is used to treat pollen-induced allergic rhinitis and upper respiratory tract allergies. Moreover, in June 2021, nasal antihistamine drugs for nonprescription use got approval from the US FDA to treat seasonal and perennial allergic rhinitis, also known as allergies.
The increase in the number of R&D activities and the introduction of novel drug therapies for the treatment of allergy diseases is expected to bring enormous growth opportunities to the market and will further aid in market expansion. However, the expiration of patented drugs and the introduction of a generic version of drugs are the restraints that may project to affect the market growth.
Segmental Outlook
The global antihistamine drugs market is segmented based on drug type, application, and end-user. Based on drug type, the market is sub-segmented into H-1 receptor antagonists (including, brompheniramine, diphenhydramine, cetirizine, desloratadine, loratadine, fexofenadine, and others) and H-2 receptor antagonists (including, cimetidine, famotidine, nizatidine, ranitidine, and other). Based on application, it is further classified into flu and cold, allergy, dermatitis, urticaria, and others. Based on end-user, the global antihistamine drugs market is categorized into home care, hospitals and clinics, and others. Among these end-users, the hospitals & clinics segment is anticipated to hold a prominent share in the market due to the increasing cases of allergic rhinitis and hay fever globally.
Regional Outlook
Geographically, the global antihistamine drugs market is classified into four major regions including North America (the US and Canada), Europe (UK, Germany, France, Italy, Spain, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia-Pacific), and Rest of the World (Latin America and the Middle East and Africa (MEA)). The Asia-Pacific region is expected to develop at a significant rate throughout the forecast period, owing to the rising frequency of allergic illnesses that has boosted the drug demand. Apart from it, the large population base and extensive government activities in the healthcare industry, especially in China are playing a critical role in the Asia-Pacific antihistamine drugs market growth.
Global Antihistamine Drugs Market Growth By Region, 2021-2028
North America Held the Significant Share in Antihistamine Drugs Market
Geographically, North America dominated the market by accounting highest market share in 2021. The region is further projected to maintain its dominance during the forecast period. The US is the major country contributing significantly to market growth and is expected to create lucrative opportunities in upcoming years. The rising prevalence of allergic rhinitis, insomnia, hay fever and surged application of antihistamine drugs in heartburns, headaches, and other treatment is the factor driving the market growth. According, to NCBI, Allergic rhinitis is a chronic upper airway inflammatory disease that affected approximately 60 million adults and children in the US. Additionally, research activities in the US for novel drug discovery, together with higher regulatory approvals, are expected to boost the expansion of the global antihistamine drug market.
Market Players Outlook
The major market players in the global antihistamine drugs market include Johnson & Johnson Services Ltd., Sanofi SA, Bayer AG, Novartis International AG, AstraZeneca PLC, GlaxoSmithKline PLC, Pfizer Inc., and Merck & Co., among others. The market players are also contributing significantly to the growth of the market by the adoption of various strategies including mergers and acquisitions, geographical expansion, partnerships, collaborations, and new product launches, to stay competitive in the market. For instance, in January 2022, Glenmark Pharmaceuticals Ltd. announced that its fully-owned Swiss subsidiary Glenmark Specialty S.A. received approval for Ryaltris, a nasal spray fixed-dose prescription drug from the US Food and Drug Administration (FDA). It is used for the treatment of seasonal allergic rhinitis.
The Report Covers
- Market value data analysis of 2021 and forecast to 2028.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global antihistamine drugs market. Based on the availability of data, information related to pipeline products, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
1. Report Summary
• Current Industry Analysis and Growth Potential Outlook
• Impact of COVID-19 on the Global Antihistamine Drugs Industry
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Region
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
3. Competitive Landscape
3.1. Key Company Analysis
3.1.1. Overview
3.1.2. Financial Analysis
3.1.3. SWOT Analysis
3.1.4. Recent Developments
3.2. Key Strategy Analysis
4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities
5. Market Segmentation
5.1. Global Antihistamine Drugs Market by Type
5.1.1. H-1 Receptor Antagonist
5.1.1.1. Brompheniramine
5.1.1.2. Diphenhydramine
5.1.1.3. Cetirizine
5.1.1.4. Desloratadine
5.1.1.5. Loratadine
5.1.1.6. Fexofenadine
5.1.1.7. Others
5.1.2. H-2 Receptor Antagonists
5.1.2.1. Cimetidine
5.1.2.2. Famotidine
5.1.2.3. Nizatidine
5.1.2.4. Ranitidine
5.1.2.5. Other
5.2. Global Antihistamine Drugs Market by Application
5.2.1. Flu and Cold
5.2.2. Allergy
5.2.3. Dermatitis
5.2.4. Urticaria
5.2.5. Others
5.3. Global Antihistamine Drugs Market by End-User
5.3.1. Homecare
5.3.2. Hospitals and Clinics
5.3.3. Others (ACS)
6. Regional Analysis
6.1. North America
6.1.1. United States
6.1.2. Canada
6.2. Europe
6.2.1. UK
6.2.2. Germany
6.2.3. Italy
6.2.4. Spain
6.2.5. France
6.2.6. Rest of Europe
6.3. Asia-Pacific
6.3.1. China
6.3.2. India
6.3.3. Japan
6.3.4. South Korea
6.3.5. Rest of Asia-Pacific
6.4. Rest of the World
6.4.1. Latin America
6.4.2. Middle East & Africa
7. Company Profiles
7.1. Akorn, Inc.
7.2. Almirall S.A.
7.3. AstraZeneca PLC
7.4. Bayer AG
7.5. Boehringer Ingelheim International GmbH.
7.6. Bristol-Myers Squibb Co.
7.7. Cadila Pharmaceuticals, Ltd.
7.8. F. Hoffmann-La Roche, Ltd.
7.9. GlaxoSmithKline PLC
7.10. Johnson & Johnson Services, Ltd.
7.11. Meda Consumer Healthcare, Inc.
7.12. Merck & Co.
7.13. Mylan N.V.
7.14. Novartis International AG
7.15. Pfizer, Inc.
7.16. Prestige Consumer Healthcare, Inc.
7.17. Sanofi S.A.
7.18. Sharp & Dohme Corp.
7.19. Teva Pharmaceutical Industries, Ltd.
1. GLOBAL ANTIHISTAMINE DRUGS MARKET RESEARCH AND ANALYSIS BY DRUG TYPE, 2021-2028 ($ MILLION)
2. GLOBAL H-1 RECEPTOR ANTAGONISTS DRUGS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
3. GLOBAL H-1 RECEPTOR ANTAGONISTS DRUGS MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
4. GLOBAL H-2 RECEPTOR ANTAGONISTS DRUGS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
5. GLOBAL H-2 RECEPTOR ANTAGONISTS DRUGS MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
6. GLOBAL BROMPHENIRAMINE MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
7. GLOBAL DIPHENHYDRAMINE MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
8. GLOBAL CETIRIZINE MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
9. GLOBAL DESLORATADINE MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
10. GLOBAL LORATADINE MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
11. GLOBAL FEXOFENADINE MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
12. GLOBAL OTHERS H-1 RECEPTOR ANTAGONISTS DRUG MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
13. GLOBAL CIMETIDINE MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
14. GLOBAL FAMOTIDINE MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
15. GLOBAL NIZATIDINE MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
16. GLOBAL RANITIDINE MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
17. OTHER H-2 RECEPTOR ANTAGONISTS DRUG MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
18. GLOBAL ANTIHISTAMINE DRUGS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
19. GLOBAL ANTIHISTAMINE DRUGS IN ALLERGY MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
20. GLOBAL ANTIHISTAMINE DRUGS IN FLU AND COLD MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
21. GLOBAL ANTIHISTAMINE DRUGS IN DERMATITIS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
22. GLOBAL ANTIHISTAMINE DRUGS IN URTICARIA MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
23. GLOBAL ANTIHISTAMINE DRUGS IN OTHERS APPLICATIONS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
24. GLOBAL ANTIHISTAMINE DRUGS MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
25. GLOBAL ANTIHISTAMINE DRUGS FOR HOMECARE MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
26. GLOBAL ANTIHISTAMINE DRUGS FOR HOSPITALS AND CLINICS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
27. GLOBAL ANTIHISTAMINE DRUGS FOR OTHERS END-USER MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
28. GLOBAL ANTIHISTAMINE DRUGS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
29. NORTH AMERICAN ANTIHISTAMINE DRUGS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
30. NORTH AMERICAN ANTIHISTAMINE DRUGS MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
31. NORTH AMERICAN ANTIHISTAMINE DRUGS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
32. NORTH AMERICAN ANTIHISTAMINE DRUGS MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
33. EUROPEAN ANTIHISTAMINE DRUGS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
34. EUROPEAN ANTIHISTAMINE DRUGS MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
35. EUROPEAN ANTIHISTAMINE DRUGS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
36. EUROPEAN ANTIHISTAMINE DRUGS MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
37. ASIA-PACIFIC ANTIHISTAMINE DRUGS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
38. ASIA-PACIFIC ANTIHISTAMINE DRUGS MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
39. ASIA-PACIFIC ANTIHISTAMINE DRUGS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
40. ASIA-PACIFIC ANTIHISTAMINE DRUGS MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
41. REST OF THE WORLD ANTIHISTAMINE DRUGS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
42. REST OF THE WORLD ANTIHISTAMINE DRUGS MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
43. REST OF THE WORLD ANTIHISTAMINE DRUGS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
44. REST OF THE WORLD ANTIHISTAMINE DRUGS MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
1. GLOBAL ANTIHISTAMINE DRUGS MARKET SHARE BY TYPE, 2021 VS 2028 (%)
2. GLOBAL ANTIHISTAMINE DRUGS MARKET SHARE BY APPLICATION, 2021 VS 2028 (%)
3. GLOBAL ANTIHISTAMINE DRUGS MARKET SHARE BY END-USER, 2021 VS 2028 (%)
4. GLOBAL ANTIHISTAMINE DRUGS MARKET SHARE BY REGION, 2021 VS 2028 (%)
5. GLOBAL H-1 RECEPTOR ANTAGONISTS DRUGS MARKET SHARE BY REGION, 2021 VS 2028 (%)
6. GLOBAL H-1 RECEPTOR ANTAGONISTS DRUGS MARKET SHARE BY TYPE, 2021 VS 2028 (%)
7. GLOBAL H-2 RECEPTOR ANTAGONISTS DRUGS MARKET SHARE BY REGION, 2021 VS 2028 (%)
8. GLOBAL H-2 RECEPTOR ANTAGONISTS DRUGS MARKET SHARE BY TYPE, 2021 VS 2028 (%)
9. GLOBAL BROMPHENIRAMINE MARKET SHARE BY REGION, 2021 VS 2028 (%)
10. GLOBAL DIPHENHYDRAMINE MARKET SHARE BY REGION, 2021 VS 2028 (%)
11. GLOBAL CETIRIZINE MARKET SHARE BY REGION, 2021 VS 2028 (%)
12. GLOBAL DESLORATADINE MARKET SHARE BY REGION, 2021 VS 2028 (%)
13. GLOBAL LORATADINE MARKET SHARE BY REGION, 2021 VS 2028 (%)
14. GLOBAL FEXOFENADINE MARKET SHARE BY REGION, 2021 VS 2028 (%)
15. GLOBAL OTHERS H-1 RECEPTOR ANTAGONISTS DRUG MARKET SHARE BY REGION, 2021 VS 2028 (%)
16. GLOBAL CIMETIDINE MARKET SHARE BY REGION, 2021 VS 2028 (%)
17. GLOBAL FAMOTIDINE MARKET SHARE BY REGION, 2021 VS 2028 (%)
18. GLOBAL NIZATIDINE MARKET SHARE BY REGION, 2021 VS 2028 (%)
19. GLOBAL RANITIDINE MARKET SHARE BY REGION, 2021 VS 2028 (%)
20. OTHER H-2 RECEPTOR ANTAGONISTS DRUG MARKET SHARE BY REGION, 2021 VS 2028 (%)
21. GLOBAL ANTIHISTAMINE DRUGS MARKET SHARE BY REGION, 2021 VS 2028 (%)
22. GLOBAL ANTIHISTAMINE DRUGS IN ALLERGY MARKET SHARE BY REGION, 2021 VS 2028 (%)
23. GLOBAL ANTIHISTAMINE DRUGS IN FLU AND COLD MARKET SHARE BY REGION, 2021 VS 2028 (%)
24. GLOBAL ANTIHISTAMINE DRUGS IN DERMATITIS MARKET SHARE BY REGION, 2021 VS 2028 (%)
25. GLOBAL ANTIHISTAMINE DRUGS IN URTICARIA MARKET SHARE BY REGION, 2021 VS 2028 (%)
26. GLOBAL ANTIHISTAMINE DRUGS FOR HOMECARE MARKET SHARE BY REGION, 2021 VS 2028 (%)
27. GLOBAL ANTIHISTAMINE DRUGS FOR HOSPITALS AND CLINICS MARKET SHARE BY REGION, 2021 VS 2028 (%)
28. GLOBAL ANTIHISTAMINE DRUGS FOR OTHERS END-USER MARKET SHARE BY REGION, 2021 VS 2028 (%)
29. US ANTIHISTAMINE DRUGS MARKET SIZE, 2021-2028 ($ MILLION)
30. CANADA ANTIHISTAMINE DRUGS MARKET SIZE, 2021-2028 ($ MILLION)
31. UK ANTIHISTAMINE DRUGS MARKET SIZE, 2021-2028 ($ MILLION)
32. FRANCE ANTIHISTAMINE DRUGS MARKET SIZE, 2021-2028 ($ MILLION)
33. GERMANY ANTIHISTAMINE DRUGS MARKET SIZE, 2021-2028 ($ MILLION)
34. ITALY ANTIHISTAMINE DRUGS MARKET SIZE, 2021-2028 ($ MILLION)
35. SPAIN ANTIHISTAMINE DRUGS MARKET SIZE, 2021-2028 ($ MILLION)
36. REST OF EUROPE ANTIHISTAMINE DRUGS MARKET SIZE, 2021-2028 ($ MILLION)
37. INDIA ANTIHISTAMINE DRUGS MARKET SIZE, 2021-2028 ($ MILLION)
38. CHINA ANTIHISTAMINE DRUGS MARKET SIZE, 2021-2028 ($ MILLION)
39. JAPAN ANTIHISTAMINE DRUGS MARKET SIZE, 2021-2028 ($ MILLION)
40. SOUTH KOREA ANTIHISTAMINE DRUGS MARKET SIZE, 2021-2028 ($ MILLION)
41. REST OF ASIA-PACIFIC ANTIHISTAMINE DRUGS MARKET SIZE, 2021-2028 ($ MILLION)
42. REST OF THE WORLD ANTIHISTAMINE DRUGS MARKET SIZE, 2021-2027($ MILLION
